"I had the pleasure of working with David recently on an early-stage market assessment / landscape analysis project and highly recommend his firm, Target2Drug BioAdvisory. From the outset, David took the time to thoroughly understand our goals and the unique situation we are in as a preclinical-stage gene therapy company in the current biotech environment. He consistently asked insightful questions to sharpen our focus and pressure-test our existing assumptions. David leveraged his deep industry knowledge with a practical, results-driven approach. His understanding of the underlying competitive influences and market dynamics in drug development, as well as the stage-appropriate needs of our company, was critical to ensuring the project remained within scope, on track, and got us the answers we needed in a compressed timeframe.

What stood out most was David’s communication and collaboration skills. It was clear he knew how to manage a diverse set of stakeholders who were responsible for the integration of the information David provided. He facilitated productive cross-functional discussions to leverage our vast internal knowledge base and point out unseen misalignments and gaps. At the conclusion of the project, those gaps had been filled and the team was well-aligned, making it seamless to incorporate David’s deliverables into our go-forward strategy. The project not only met but exceeded my expectations, delivering long-term value to our organization. I would not hesitate to engage David again for future projects and can confidently recommend him to any organization looking for a reliable, skilled, and results-oriented consultant"

​

- Beckett Hart, Head of Corporate Development and Strategy